Ventas Inc (FRA:VEN) Stock Price, Trades & News

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Financial Strength

4/10

Name	Current	Vs Industry
Cash-To-Debt	0.01
Equity-to-Asset	0.47
Debt-to-Equity	0.97
Debt-to-EBITDA	5.42
Interest Coverage	1.4
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.09	Distress Grey Safe
Beneish M-Score	-2.58	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

7/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	7.2
	3-Year EBITDA Growth Rate	6.9
	3-Year FCF Growth Rate	9.5
	3-Year Book Growth Rate	1.3
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	39.84
	Future 3-5Y Total Revenue Growth Rate Estimate	10.71

Momentum Rank

9/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	78.76
	9-Day RSI	68.3
	14-Day RSI	62.14
	3-1 Month Momentum %	6.81
	6-1 Month Momentum %	13.52
	12-1 Month Momentum %	40.02

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	0.49
	Quick Ratio	0.49
	Cash Ratio	0.13
	Days Sales Outstanding	14.03
	Days Payable	119.76

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	2.2
	Dividend Payout Ratio	4.15
	3-Year Dividend Growth Rate	2.2
	Forward Dividend Yield %	2.24
	5-Year Yield-on-Cost %	2.03
	3-Year Average Share Buyback Ratio	-5.9
	Shareholder Yield %	-1.93

Profitability Rank

6/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	40.69
	Operating Margin %	14.16
	Net Margin %	4.25
	EBITDA Margin %	38.26
	FCF Margin %	17.1
	OCF Margin %	28.05
	ROE %	2.13
	ROA %	0.97
	ROIC %	3.33
	3-Year ROIIC %	19.5
	ROCE %	3.41
	Years of Profitability over Past 10-Year	8
	Moat Score	6
	Tariff Resilience Score	8

GF Value Rank

5/10

	Name	Current	Vs Industry		Vs History
	Price-to-FFO	25.04
	PE Ratio	161.91
	Forward PE Ratio	147.36
	PE Ratio without NRI	188.67
	Shiller PE Ratio	72.43
	Price-to-Owner-Earnings	36.35
	PEG Ratio	943.35
	PS Ratio	6.87
	PB Ratio	3.3
	Price-to-Tangible-Book	3.59
	Price-to-Free-Cash-Flow	40.06
	Price-to-Operating-Cash-Flow	24.44
	EV-to-EBIT	64.12
	EV-to-Forward-EBIT	64.85
	EV-to-EBITDA	23.82
	EV-to-Forward-EBITDA	22.07
	EV-to-Revenue	9.11
	EV-to-Forward-Revenue	8.21
	EV-to-FCF	53.36
	Price-to-GF-Value	1.27
	Price-to-Projected-FCF	2.45
	Price-to-Median-PS-Value	1.24
	Price-to-Graham-Number	5.48
	Earnings Yield (Greenblatt) %	1.56
	FCF Yield %	2.42
	Forward Rate of Return (Yacktman) %	4.51

Financials (Next Earnings Date:2026-07-30 Est.)

Annual Quarterly TTM

FRA:VEN's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Ventas Inc Operating Data

Annual Quarterly

FRA:VEN's Complete Operating Data

No operating data available for Ventas Inc.

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Ventas Inc Executives

Details

GF Value™: €59.93

FRA:VEN

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with VEN. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	5,271.175
	EPS (TTM) (€)	0.472
	Beta	0.5997
	3-Year Sharpe Ratio	0.92
	3-Year Sortino Ratio	1.71
	Volatility %	20.74
	14-Day RSI	62.14
	14-Day ATR (€)	1.07861
	20-Day SMA (€)	71.604
	12-1 Month Momentum %	40.02
	52-Week Range (€)	53.08 - 76.78
	Shares Outstanding (Mil)	486.17

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Ventas Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Ventas Inc Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-10-30 10:00	In 125 days
Third quarter earnings results for 2026	2026-10-29	In 123 days
Second quarter earnings conference call for 2026	2026-07-31 10:00	In 34 days
Second quarter earnings results for 2026	2026-07-30	In 32 days
USD 0.520000 Cash Dividend	2026-06-30	In 2 days
General meeting for 2026	2026-05-13 08:00	74.16 (+0.00%)
First quarter earnings conference call for 2026	2026-04-28 10:00	70.84 (+0.00%)
First quarter earnings results for 2026	2026-04-27	70.58 (+0.00%)
USD 0.520000 Cash Dividend	2026-03-31	70.98 (+0.00%)
Guidance call for 2026	2026-03-04 10:25	73.28 (+0.00%)

Show

Entries

Ventas Inc Frequently Asked Questions

What is Ventas Inc(FRA:VEN)'s stock price today?

The current price of FRA:VEN is €76.26. The 52 week high of FRA:VEN is €76.78 and 52 week low is €53.08.

When is next earnings date of Ventas Inc(FRA:VEN)?

The next earnings date of Ventas Inc(FRA:VEN) is 2026-07-30 Est..

Does Ventas Inc(FRA:VEN) pay dividends? If so, how much?

The Dividend Yield % of Ventas Inc(FRA:VEN) is 2.2% (As of Today), Highest Dividend Payout Ratio of Ventas Inc(FRA:VEN) was 14.75. The lowest was 1.19. And the median was 2.72. The Forward Dividend Yield % of Ventas Inc(FRA:VEN) is 2.24%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
	Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research	2026-06-22
	Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement	2026-06-03
	Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference	2026-06-01
	Ventas Reports 2026 First Quarter Results	2026-04-27
	Ventas Announces First Quarter 2026 Earnings Release Date and Conference Call	2026-04-02
	Ventas Issues Investor Presentation for Upcoming Investor Conferences	2026-03-02
	Ventas Reports Fourth Quarter and Full Year 2025 Results, Provides 2026 Outlook and Increases Dividend	2026-02-05
	Ventas Announces Tax Treatment of 2025 Distributions	2026-01-20
	Ventas Announces Fourth Quarter 2025 Earnings Release Date and Conference Call	2026-01-14
	Ventas Declares Quarterly Dividend of $0.48 Per Common Share	2025-12-10

10/Page

Articles on Ventas Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.